Avvisto Therapeutics LLC
UnclaimedPharmaceutical Preparation ManufacturingTiverton, RI
Founded
2024
Primary NAICS
325412
CAGE code
06N17
Federal awards
—
Overview
Avvisto Therapeutics Cycloset Cycloset® – a unique sympatholytic, dopamine agonist- insulin sensitizer, FDA Approved Product for the Treatment of Type 2 Diabetes Science and Technology Scores of pre-clinical and clinical studies manifested the FDA approval of Cycloset for Type 2 Diabetes. Click here to view selected peer-reviewed publications Patient Information Click here to view patient […]
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Veterans Affairs | $0 | 2 |
| 2025 | Department of Veterans Affairs | $0 | 2 |